Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mikhail Kharitonov (St Petersburg, Russian Federation), Mikhail Kharitonov, Mikhail Zhurkin, Vladimir Ivanov, Andrey Nikolaev, Sergey Kotov, Svetlana Rubova. Modern etiology of severe community-acquired pneumonia. Eur Respir J 2016; 48: Suppl. 60, 2583

Member's Comments

No comment yet.

Related content which might interest you: Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Healthcare-associated pneumonia: Comparative characteristics with community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Influence of comorbidities on pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Physical deterioration during hospitalization in patients with community-acquired pneumonia Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Severe community-acquired pneumonia Source: Eur Respir Monogr 2016; 74: 101-116 Year: 2016 Cardiovascular autonomic alterations and severity of the disease in community-acquired pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Etiology of severe community-acquired pneumonia in Japan Source: Eur Respir J 2005; 26: Suppl. 49, 256s Year: 2005 Community-acquired pneumonia with severe sepsis: Etiology and prognosis Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Bacteraemia in outpatient with community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Treatment of severe community-acquired pneumonia: new horizons Source: International Congress 2014 – Advances in managing acute respiratory failure Year: 2014 The prevalence of cardiac diseases in patients with community-acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Surfactant-enforced treatment of pseudomonas-induced pneumonia Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 The impact of mixed etiology in community acquired pneumonia (CAP) Source: International Congress 2014 – Respiratory infections: inflammation and treatment Year: 2014